3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
2
Melanoma
2
Lymphoma
2
Lung Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Mouth Neoplasms
1
Hematologic Neoplasms
1
Glioma
1
Fanconi Anemia
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
Whole-Body Irradiation
3
fludarabine phosphate
2
Mycophenolic Acid
2
Melphalan
2
Cyclosporine
2
Cyclophosphamide
2
Busulfan
2
tocilizumab
1
ruxolitinib
1
iadademstat
1
decitabine and cedazuridine drug combination
1
Tacrolimus
1
Specimen Handling
1
Sirolimus
1
Rituximab
1
Peripheral Blood Stem Cell Transplantation
1
Methotrexate
1
Hyperbaric Oxygenation
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Etoposide
1
Cord Blood Stem Cell Transplantation
1
Clofarabine
1
CT-P10
1
CPI-0610
1
Blood Specimen Collection
1
Biopsy
1
Antilymphocyte Serum
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic-Myeloproliferative Diseases
×
Afatinib
×
30 days
×
Clear all
No trials found.